NCT04829487

Brief Summary

The purpose of this study is to evaluate the effect of vitamin D supplementation on the pain score of primary dysmenorrhea. Our hypothesis is that by normalizing vitamin D level could help improve pain score of women who have primary dysmenorrhea.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2021

Typical duration for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 31, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 2, 2021

Completed
29 days until next milestone

Study Start

First participant enrolled

May 1, 2021

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2023

Completed
Last Updated

April 2, 2021

Status Verified

March 1, 2021

Enrollment Period

2 years

First QC Date

March 31, 2021

Last Update Submit

March 31, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Visual analog pain scale

    Pain score between intervention and placebo group after treatment

    8 weeks

Study Arms (2)

Vitamin D

EXPERIMENTAL

Vitamin D 50,000 IU orally weekly for 8 weeks

Drug: Ergocalciferol Capsules

Placebo

PLACEBO COMPARATOR

Placebo capsules orally weekly for 8 weeks

Drug: Placebo

Interventions

Given to subjects 50,000 IU per week for 8 weeks

Also known as: Vitamin D2
Vitamin D

Placebo capsules

Placebo

Eligibility Criteria

Age18 Years - 30 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Primary dysmenorrhea
  • Hypovitaminosis D

You may not qualify if:

  • Using calcium, magnesium or phosphorus in the past 3 months
  • Using hormonal contraception or IUD in the past 6 months
  • No smoking or alcohol drinking
  • Chronic underlying diseases
  • Allergic to components in study drugs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Vitamin D Deficiency

Interventions

Ergocalciferols

Condition Hierarchy (Ancestors)

AvitaminosisDeficiency DiseasesMalnutritionNutrition DisordersNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

CholestenesCholestanesSteroidsFused-Ring CompoundsPolycyclic CompoundsSterolsVitamin DSecosteroidsMembrane LipidsLipids

Study Officials

  • Mananya Silpakit, Doctor

    Reproductive medicine unit, Department of OB-GYN, Faculty of Medicine, Siriraj Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mananya Silpakit, Doctor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomised controlled study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

March 31, 2021

First Posted

April 2, 2021

Study Start

May 1, 2021

Primary Completion

April 30, 2023

Study Completion

April 30, 2023

Last Updated

April 2, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share